Heron Therapeutics, Inc.

Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a …

Biotechnology

US, San Diego [HQ]

Board & Officers
Business Intelligence
Employee Voice
Mergers and Acquisitions
Qualified Risks
ESG Scores [Soon]

Strategy & Leadership

Officers & BofD Beta

All directors and officers of Heron Therapeutics, Inc. are sourced directly from the SEC or manually.
For the SEC we either use the Form 3/4/5 or, even better extract the compensation for each leader out of the audited proxy statement (DEF-14A).

Form 3/4/5
Proxy DEF-14A

Total Compensation

Shows the total compensation per mentioned executive and board director.
Each datapoint refers the most recent appearance of the corresponding person.

- No data, only available if we have DEF 14A compensations in place -

Officers

Name & Position	Research
Duarte Ira EVP, Chief Financial Officer	Transactions Compensations Speech	10/21/24 [Form 4]
Forbes William P EVP, Chief Development Officer	Transactions Compensations Speech	10/21/24 [Form 4]
Collard Craig A Chief Executive Officer Also inside the BofD	Transactions Compensations Speech	10/21/24 [Form 4]
Peraza Lisa VP, Chief Accounting Officer	Transactions Compensations Speech	01/19/24 [Form 4]
Szekeres David Leslie EVP, Chief Operating Officer	Transactions Compensations Speech	07/17/23 [Form 4]
Poyhonen John President & CCO	Transactions Compensations Speech	04/17/23 [Form 4]
Manhard Kimberly EVP, Drug Development	Transactions Compensations Speech	04/17/23 [Form 4]

Board of Directors (BofD)

Name & Position	Research
Kaseta Michael Director	Transactions Compensations Speech	11/06/24 [Form 4]
Christian Waage Director	Transactions Compensations Speech	01/19/24 [Form 4]
Rodriguez Susan Director	Transactions Compensations Speech	01/19/24 [Form 4]
Morgan Adam Director	Transactions Compensations Speech	01/19/24 [Form 4]
Johnson Craig A Director	Transactions Compensations Speech	01/19/24 [Form 4]
Dissanaike Sharmila Director	Transactions Compensations Speech	01/19/24 [Form 4]
Kotler Kevin Director	Transactions Compensations Speech	03/02/23 [Form 3]